DOCSLIB.ORG

WO 2018/004338 Al 04 January 2018 (04.01.2018) W !P O PCT

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WO 2018/004338 Al 04 January 2018 (04.01.2018) W !P O PCT (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/004338 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: o Vondellaan 11, 561 1 NX Eindhoven (NL). HOEBEN, A61K 47/54 (2017.01) B82Y 5/00 (201 1.01) Freek Johannes Maria; c/o Vondellaan 11, 561 1NX Ein d A61K 47/69 (2017.01) C07D 257/08 (2006.01) hoven (NL). VERSTEEGEN, Ronny Mathieu; c/o Von dellaan 11, 561 1NX Eindhoven (NL). JANSSEN, Hendri- (21) International Application Number: cus Marie; c/o Vondellaan 11, 561 1 NX Eindhoven (NL). PCT/NL20 17/050427 VAN ONZEN, Arthur Henry Antoon Marie; c/o Vondel (22) International Filing Date: laan 11, 561 1NX Eindhoven (NL). ROSSIN, Raffaella; c/ 27 June 2017 (27.06.2017) o Vondellaan 11, 561 1 NX Eindhoven (NL). (25) Filing Language: English (74) Agent: JANSEN, CM.; V.O., Carnegieplein 5, 2517 KJ Den Haag (NL). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 16176416.2 27 June 2016 (27.06.2016) EP AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (71) Applicant: TAGWORKS PHARMACEUTICALS B.V. CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, [NL/NL]; Vondellaan 11, 561 1 NX Eindhoven (NL). DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (72) Inventors: ROBILLARD, Marc Stefan; c/o Vondellaan KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 11, 561 1 NX Eindhoven (NL). TEN HOEVE, Wolter; c/ MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (54) Title: CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION Fig. 1 o (57) Abstract: Disclosed is an advancement in provoked chemical cleavage. Thereby the invention provides the use of a diene as a chemically cleavable group attached to a Construct, and the use of a dienophile to provoke the release of the Construct by allowing the diene to react with a dienophile capable of undergoing an inverse electron demand Diels Alder reaction with the diene. The invention o includes a kit for releasing a Construct C bound to a Trigger T , the kit comprising a tetrazine and a dienophile, wherein the Trigger © is the tetrazine. The invention also includes the use of the formation of a pyridazine by reacting a tetrazine comprising a Construct 00 C bound thereto and a dienophile, as a chemical tool for the release, in a chemical, biological or physiological environment, of said o Construct. o [Continued on nextpage] WO 2018/004338 Al llll II II 11III II I II II i II 11III II I II OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION FIELD OF THE INVENTION The invention pertains to the field of provoked chemical cleavage. Particularly, the invention pertains to providing chemical substances with a functional group capable of acting as a Trigger for release of an entity attached to said chemical group. This plays a role, e.g., in drug delivery, prodrug activation, modification of molecules under physiological conditions (e.g., in a cellular environment), in solid phase synthesis, biomolecule interactions, modification of surfaces (including cell surfaces). BACKGROUND The current state of the art in organic chemistry enables the preparation of highly complex molecular structures, by application of a wide toolbox of synthetic transformations. Unfortunately, the vast majority of chemical techniques is executed under strictly defined conditions, requiring toxic solvents, stoichiometric reagents, extreme temperatures, exclusion of moisture or oxygen, and with carefully designed protective group protocols. One of the most difficult challenges in synthetic chemistry remains the ability to have precise control over chemical reactivity and selectivity. These demands are amplified when it is necessary to perform selective reactions in chemically complex environments, such as those found in biology. Unfortunately, only a few chemical transformations are so mild and precise that they can be used to selectively modify biochemical structures, such as proteins or nucleic acids, which typically proceed in water and at near-ambient temperature. Moreover, such biomolecular modification must be highly chemospecific in the sense that only a single functionality of interest is selectively modified in the presence of a plethora of other functional groups. Even more challenging is to apply a chemical reaction on or in living cells or whole organisms. Selective chemical reactions that are orthogonal to the diverse functionality of biological systems are called bio-orthogonal reactions and occur between two abiotic groups with exclusive mutual reactivity. Truly bio-orthogonal reactions are not yet available as each reaction so far is orthogonal to a subset of the functionalities found in biological systems. Thus, extremely selective and high-yielding bio-orthogonal coupling chemistry reactions continue to receive interest. Bio-orthogonal reactions are broadly useful tools with applications that span synthesis, materials science, chemical biology, diagnostics, and medicine. They are generally used in coupling reactions of small molecules, peptides, proteins, oligonucleotides, other types of polymers, glycans, nanoparticles, and on surfaces (e.g., glass slides, gold, resins). Further examples include: compound library synthesis, protein engineering, functional proteomics, activity-based protein profiling, target guided synthesis of enzyme inhibitors, chemical remodeling of cell surfaces, tracking of metabolite analogues, and imaging tagged biomolecules in live cells and animals. Analogous to selective coupling reactions, chemoselective cleavable linkers and protecting groups have widespread application in the manipulation of conjugates and derivatives of: small molecules, polymers, and biomolecules such as peptides, proteins and DNA within the context of chemical synthesis, materials science, chemical biology, diagnostics, and medicine. [G.C. Rudolf, W. Heydenreuter, S.A. Sieber, Curr. Opin. Chem. Biol. 2013, 17, 110-117] For example, linker systems that allow mild cleavage under conditions ideally orthogonal to functionalities present in the biological system at hand have found application in activity- based protein profiling. Protease substrates linked to a biotin tag through a cleavable linker have been used to capture and isolate specific enzymes by the binding of the biotin tag to avidin coated resin or beads. Subsequently the captured complex can then be released under mild conditions by cleavage of the linker instead of having to break the biotin-avidin interaction. Also, chemically cleavable linkers have emerged as powerful tools in solid-phase organic synthesis, especially for the rapid production of highly diverse organic compound libraries created through combinatorial or parallel chemistry methods. Especially prominent application areas for cleavable linkers include drug delivery agents and prodrugs for pharmaceutical applications, as well as various reversible bioconjugates and sophisticated spectroscopic bioprobes for applications in the field of biological analysis. However, chemoselective cleavable linkers and protecting groups have a limited orthogonality compared to the relatively highly bio-orthogonal coupling reactions listed above and with respect to the wide range of functionalities present in the complex environments encountered e.g. in vivo, in biological media, biomolecules, or complex materials. A wider and more uniform application scope may be achieved for chemoselective linkers and protecting groups if the aforementioned bio-orthogonal coupling reactions could be adapted to effect selective release instead of selective conjugation. We have demonstrated that the fastest click reaction, the inverse-electron-demand Diels Alder (IEDDA) reaction, can be used for pretargeted radioimmunoimaging, treating tumor-bearing mice with irafts-cyclooctene(TCO)-tagged antibody or antibody fragments, followed 1-3 days later by administration and selective conjugation of a radiolabeled tetrazine probe to the TCO tag of the tumor-bound antibody [Rossin, M. S. Robillard, Curr. Opin. Chem. Biol. 2014, 21, 161-169]. Based on the IEDDA conjugation we have recently developed a new release reaction, which we termed the IEDDA pyridazine elimination, a "click-to-release" approach that affords instantaneous and selective release upon conjugation [R. M. Versteegen, R. Rossin, W. ten Hoeve, H. M. Janssen, M. S. Robillard, Angew. Chem. Int. Ed. 2013, 52, 14112-14116]. IEDDA reactions between tetrazines (i.e. diene) and alkenes (i.e. dienophile) afford 4,5-dihydropyridazines, which usually tautomerize to 1,4- and 2,5-dihydropyridazines. We demonstrated that the 1,4-dihydropyridazine product derived from a TCO containing a carbamate-linked doxorubicin (Dox) at the allylic position and tetrazine is prone to eliminate C0 2 and Dox via a novel electron cascade mechanism eventually affording aromatic pyridazine. The triggered release has been demonstrated in PBS (phosphate buffered saline), serum, cell culture and in mice and holds promise for a range of applications in medicine, chemical biology, and synthetic chemistry, including triggered drug release, biomolecule uncaging and capture&release strategies. Aforementioned technology has also been disclosed in WO2012/156919, WO2012156918A1, WO 2014/081303, and US20 150297741. Herein a dienophile is used as a chemically cleavable group.
Load more

Recommended publications
  • WSC 2000-01 Conference 1
    The Armed Forces Institute of Pathology Department of Veterinary Pathology WEDNESDAY SLIDE CONFERENCE 2002-2003 CONFERENCE 17 12 February 2003 Conference Moderator: LTC Gary Zaucha, DVM Diplomate, ACVP, ABT, and ACVPM Chief, Department of Comparative Pathology Walter Reed Army Institute of Research Silver Spring, MD 20910 CASE I – 1614-1 (AFIP 2850109) Signalment: 5-month-old outbred female Swiss-Webster mouse History: Sentinel mouse in a laboratory colony housed on dirty bedding from other mouse cages, part of an infectious disease surveillance program. Euthanized due to lethargy and unthriftiness. Gross Pathology: Stomach distended approximately three times by gas, fluid, and partially digested food. Kidneys shrunken, pale, and pitted. Multifocal hemorrhagic necrosis and thrombosis of the ovaries bilaterally. Laboratory Results: Negative for all murine infectious pathogens tested in the colony surveillance program by serology, respiratory and intestinal cultures, fecal examination, anal tape, and skin scrapings. Contributor’s Morphologic Diagnosis: Kidney: Chronic nephropathy characterized by membranous glomerulopathy, lymphoplasmacytic adventitial vasculitis and perivasculitis, tubular degeneration, ectasia, and regeneration with protein, hemoglobin, cellular, waxy, and granular casts, and lymphoplasmacytic and histiocytic interstitial nephritis, severe. Contributor’s Comment: This case is consistent with the previously reported syndrome of gastric dilatation and chronic nephropathy in mice exposed to dirty bedding [1]. Although the mean age of affected mice in the published report was 10 months, similar lesions are sometimes found in animals as young as 3 or 4 months of age. The kidney disease appears immune-mediated and is presumably the result of chronic high antigen exposure, although there may be more than one inciting process.
    [Show full text]
  • Determination of Mushroom Toxin Alpha-Amanitin in Serum by Liquid Chromatography-Mass Spectrometry After Solid-Phase Extraction
    Original article UDC: 615.918:582.28 doi:10.5633/amm.2015.0102 DETERMINATION OF MUSHROOM TOXIN ALPHA-AMANITIN IN SERUM BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY AFTER SOLID-PHASE EXTRACTION Maja Vujović1,2, Ivana Ilić3, Vesna Kilibarda4 University of Niš, Faculty of Medicine, Department of Pharmacy, Serbia1 Institute of Forensic Medicine, Niš, Serbia2 University of Niš, Faculty of Medicine, Serbia3 Military Medical Academy Belgrade, National Poison Control Centre, Serbia4 Alpha-amanitin is a cyclic peptide which belongs to a large group of mushroom toxins known as amatoxins. Being responsible for the majority of fatal mushroom poisonings, they require rapid detection and excretion from the body fluids. In accordance with these requirements, a simple and an accurate method was developed for successful identification and quantification of alpha-amanitin in serum with electrospray liquid chromatography–mass spectrometry (LC-ESI-MS) after collision-induced dissociation. The method conforms to the established International Conference on Harmonization Q2A/Q2B 1996 guidelines on the validation of analytical methods. Linearity, precision, extraction recovery and stability test on blank serum spiked with alpha-amanitin and stored in different conditions met the acceptance criteria. The obtained calibration curve was linear over the concentration range 5-100 ng/mL with a lower limit of quantification (LOQ) of 5 ng/mL and limit of detection (LOD) of 2.5 ng/mL. The mean intra- and inter-day precision and accuracy were 6.05% and less than ±15% of nominal values, respectively. The neutral solid phase extraction with copolymer hydrophilic–lipophilic balance cartridges was found optimal for sample preparation with the mean recovery of 91.94%.
    [Show full text]
  • Poisonous Mushrooms; a Review of the Most Common Intoxications A
    Nutr Hosp. 2012;27(2):402-408 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 Revisión Poisonous mushrooms; a review of the most common intoxications A. D. L. Lima1, R. Costa Fortes2, M. R.C. Garbi Novaes3 and S. Percário4 1Laboratory of Experimental Surgery. University of Brasilia-DF. Brazil/Paulista University-DF. Brazil. 2Science and Education School Sena Aires-GO/University of Brasilia-DF/Paulista University-DF. Brazil. 3School of Medicine. Institute of Health Science (ESCS/FEPECS/SESDF)/University of Brasilia-DF. Brazil. 4Institute of Biological Sciences. Federal University of Pará. Brazil. Abstract HONGOS VENENOSOS; UNA REVISIÓN DE LAS INTOXICACIONES MÁS COMUNES Mushrooms have been used as components of human diet and many ancient documents written in oriental coun- Resumen tries have already described the medicinal properties of fungal species. Some mushrooms are known because of Las setas se han utilizado como componentes de la their nutritional and therapeutical properties and all over dieta humana y muchos documentos antiguos escritos en the world some species are known because of their toxicity los países orientales se han descrito ya las propiedades that causes fatal accidents every year mainly due to medicinales de las especies de hongos. Algunos hongos misidentification. Many different substances belonging to son conocidos por sus propiedades nutricionales y tera- poisonous mushrooms were already identified and are péuticas y de todo el mundo, algunas especies son conoci- related with different symptoms and signs. Carcino- das debido a su toxicidad que causa accidentes mortales genicity, alterations in respiratory and cardiac rates, cada año, principalmente debido a errores de identifica- renal failure, rhabidomyolisis and other effects were ción.
    [Show full text]
  • AMATOXINS in EDIBLE MUSHROOMS H. FAULSTICH* And
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 64, number I FEBS LETTERS April 1976 AMATOXINS IN EDIBLE MUSHROOMS H. FAULSTICH* and M. COCHET-MEILHAC** Max-Planck-Institut fiir medizinische Forschungp Abteilung Naturstoff-Chemie, Jahnstr. 29, D-69 Heidelberg, F. R. G., and **Institut de Chimie Biologique, Unit& de Recherche sur le Cancer de I’INSERM et Centre de Neurochimie du C.N.R.S., FacultP de Midecine, F-67085 Strasbourg, France Received 9 February 1976 1. Introduction 2. Materials and methods The toxic cyclopeptides in Amanita phalloides All mushrooms of the Amanita species, except mushrooms weigh about 0.05% of the fresh tissue. A. rubescens and A. pantherina, were harvested near Two-thirds of this weight are phallotoxins, mostly the Trento (Italy) in 1974. The others were collected acidic compounds phallacidin and phallisacin [ 1,2] , near Heidelberg in 1975. The tissues (20-80 g) were the rest being amatoxins, predominantly cr-amanitin. homogenized in a Star mixer together with a two-fold A combination of chromatographic procedures [3] volume of methanol and then kept under stirring at permits the spectrophotometric determination of up 70°C for 1 h. After centrifugation the supernatant to 11 toxic compounds [4] in single mushrooms. The was evaporated in vacua. The residues were thoroughly sensitivity of this analysis is limited to 0.1 pg of each dried, washed with dry ether and dissolved in 2 ml of toxin, this being sufficient, however, to determine 5 water. The amatoxins were extracted from these different amatoxins in A.
    [Show full text]
  • Determination of Mushroom Toxin Alpha-Amanitin in Serum by Liquid Chromatography-Mass Spectrometry After Solid-Phase Extraction
    Original article UDC: 615.918:582.28 doi:10.5633/amm.2015.0102 DETERMINATION OF MUSHROOM TOXIN ALPHA-AMANITIN IN SERUM BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY AFTER SOLID-PHASE EXTRACTION Maja Vujović1,2, Ivana Ilić3, Vesna Kilibarda4 University of Niš, Faculty of Medicine, Department of Pharmacy, Serbia1 Institute of Forensic Medicine, Niš, Serbia2 University of Niš, Faculty of Medicine, Serbia3 Military Medical Academy Belgrade, National Poison Control Centre, Serbia4 Alpha-amanitin is a cyclic peptide which belongs to a large group of mushroom toxins known as amatoxins. Being responsible for the majority of fatal mushroom poisonings, they require rapid detection and excretion from the body fluids. In accordance with these requirements, a simple and an accurate method was developed for successful identification and quantification of alpha-amanitin in serum with electrospray liquid chromatography–mass spectrometry (LC-ESI-MS) after collision-induced dissociation. The method conforms to the established International Conference on Harmonization Q2A/Q2B 1996 guidelines on the validation of analytical methods. Linearity, precision, extraction recovery and stability test on blank serum spiked with alpha-amanitin and stored in different conditions met the acceptance criteria. The obtained calibration curve was linear over the concentration range 5-100 ng/mL with a lower limit of quantification (LOQ) of 5 ng/mL and limit of detection (LOD) of 2.5 ng/mL. The mean intra- and inter-day precision and accuracy were 6.05% and less than ±15% of nominal values, respectively. The neutral solid phase extraction with copolymer hydrophilic–lipophilic balance cartridges was found optimal for sample preparation with the mean recovery of 91.94%.
    [Show full text]
  • Amanita Phalloides Poisoning: Mechanisms of Toxicity and Treatment
    Food and Chemical Toxicology 86 (2015) 41–55 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Review Amanita phalloides poisoning: Mechanisms of toxicity and treatment Juliana Garcia a,∗, Vera M. Costa a, Alexandra Carvalho b, Paula Baptista c,PaulaGuedesde Pinho a, Maria de Lourdes Bastos a, Félix Carvalho a,∗∗ a UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua José Viterbo Ferreiran° 228, 4050-313 Porto, Portugal b Department of Cell and Molecular Biology, Computational and Systems Biology, Uppsala University, Biomedical Center, Box 596, 751 24 Uppsala, Sweden c CIMO/School of Agriculture, Polytechnique Institute of Bragança, Campus de Santa Apolónia, Apartado 1172, 5301-854 Bragança, Portugal article info abstract Article history: Amanita phalloides, also known as ‘death cap’, is one of the most poisonous mushrooms, being involved Received 10 April 2015 in the majority of human fatal cases of mushroom poisoning worldwide. This species contains three main Received in revised form 8 September 2015 groups of toxins: amatoxins, phallotoxins, and virotoxins. From these, amatoxins, especially α-amanitin, Accepted 10 September 2015 are the main responsible for the toxic effects in humans. It is recognized that α-amanitin inhibits RNA Available online 12 September 2015 polymerase II, causing protein deficit and ultimately cell death, although other mechanisms are thought Keywords: to be involved. The liver is the main target organ of toxicity, but other organs are also affected, especially Amanita phalloides the kidneys. Intoxication symptoms usually appear after a latent period and may include gastrointestinal Amatoxins disorders followed by jaundice, seizures, and coma, culminating in death.
    [Show full text]
  • | Hai Lala Mo at Alt a La La La Manual
    |HAI LALA MO ATUS009938323B2 ALT A LA LA LA MANUAL (12 ) United States Patent ( 10 ) Patent No. : US 9 ,938 , 323 B2 Grunewald et al. (45 ) Date of Patent : Apr . 10 , 2018 ( 54 ) AMATOXIN DERIVATIVES AND WO 2014135282 AL 9 / 2014 CONJUGATES THEREOF AS INHIBITORS WO 2014141094 Al 9 / 2014 OF RNA POLYMERASE WO 2016142049 AL 9 / 2016 (71 ) Applicant: NOVARTIS AG , Basel (CH ) OTHER PUBLICATIONS ( 72 ) Inventors : Jan Grunewald , San Diego , CA (US ) ; Yunho Jin , San Diego , CA (US ) ; Zhao , et al ., “ Synthesis of a Cytotoxic Amanitin for Biorthogonal Weijia Ou , San Diego , CA (US ) ; Conjugation ” , ChemBioChem , 2015 , pp . 1420 - 1425, vol . 16 , Tetsuo Uno , San Diego , CA (US ) Wiley - VCH Verlag GmbH & Co . Adair, et al ., “ Antibody -drug conjugates a perfect synergy ” , ( 73 ) Assignee : Novartis AG , Basel (CH ) Expert Opin . Biol. Ther. , 2012 , pp . 1191 - 1206 , vol. 12 , No . 9 , Informa UK , Ltd . ( * ) Notice : Subject to any disclaimer , the term of this Flygare , et al ., “ Antibody - Drug Conjugates for the Treatment of patent is extended or adjusted under 35 Cancer ” , Chem . Biol . Drug . Des. , 2013 , pp . 113 - 121 , vol. 81 , John Wiley & Sons A / S . U . S . C . 154 ( b ) by 0 days . Jackson , et al ., “ Using the Lessons Learned from the Clinic to Improve the Preclinical Development of Antibody Drug Conju (21 ) Appl. No. : 15 /524 , 197 gates ” , Pharm . Res . , 2014 , pp . 1 - 12 . (22 ) PCT Filed : Nov. 5 , 2015 (Continued ) ( 86 ) PCT No. : PCT/ IB2015 /058537 Primary Examiner — Jeanette Lieb $ 371 ( c ) ( 1 ) , ( 74 ) Attorney , Agent, or Firm — Daniel E . Raymond ; ( 2 ) Date : May 3, 2017 Genomics Institute of the Novartis Research Foundation ( 87) PCT Pub .
    [Show full text]
  • Deactivation Study of Α-Amanitin Toxicity in Poisonous Amanita Spp
    orensi Narongchai and Narongchai, J Forensic Res 2017, 8:6 f F c R o e l s a e n DOI: 10.4172/2157-7145.1000396 r a r u c o h Journal of J ISSN: 2157-7145 Forensic Research Research Article Open Access Deactivation Study of α-Amanitin Toxicity in Poisonous Amanita spp. Mushrooms by the Common Substances In Vitro Paitoon Narongchai* and Siripun Narongchai Department of Forensic Medicine, Faculty of Medicine, ChiangMai University, Chiang Mai, Thailand Abstract The purpose of this research was to find out the substance which deactivate α-AmanitinToxicity The materials and methods used in the study include analysis with high performance liquid chromatography (HPLC) to: 1.Demonstrate the standard α-amanitin at concentrations of 25, 50 and 100 µg/ml 2.Determine the deactivation of α-amanitin with 1) 18% acetic acid 2), calcium hydroxide 40 mg/ml, 3) potassium permanganate 20 mg/ml, 4) sodium bicarbonate 20 mg/ml 3.Report the statistical analysis as the mean ± standard deviation (SD) and paired t-test. The result revealed that potassium permanganate could eliminate 100 percent of the α-amanitin at 25, 50 and 100 µg/ml. Calcium hydroxide, sodium bicarbonate and acetic acid had lower elimination rates at those concentrations: 68.43 ± 2.58 (-71.4, -67.2, -66.7%), 21.48 ± 10.23 (-29.4, -25.2, -9.9%) and 3.21 ± 0.02% (-3.2, -3.2, +1.1%), respectively. The conclusion of this study was suggested that potassium permanganate could be applied as an absorbent substance during gastric lavage in patients with mushroom poisoning.
    [Show full text]
  • Identification of Forensically Relevant Oligopeptides of Poisonous Mushrooms with Capillary Electrophoresis-ESI-Mass Spectrometry
    Identification of forensically relevant oligopeptides of poisonous mushrooms with capillary electrophoresis-ESI-mass spectrometry J. Rittgen, M. Pütz, U. Pyell Abstract Over 90% of the lethal cases of mushroom toxin poisoning in man are caused by a species of Amanita. They contain the amatoxins α-, β-, γ- and ε-amanitin, amanin and amanullin together with phallotoxins and virotoxins. The identification of the named toxicants in intentionally poisoned samples of foodstuff and beverages is of significant forensic interest. In this work a CE-ESI-MS procedure was developed for the separation of five forensically relevant oligopeptides including α-, β- and γ-amanitin, phalloidin and phallacidin. The running buffer consisted of 20 mmol/l ammonium formate at pH 10.8 and 10% (v/v) isopropanol. Dry nitrogen gas was delivered at 4 l/min at 250°C. The pressure of nebulizing nitrogen gas was set at 4 psi. The sheath liquid was isopropanol/water (50:50, v/v) at a flow rate of 3 µl/min. A mass range between 600 and 1000 m/z and negative as well as positive polarity detection mode was selected. The separation of the five negatively charged analytes was achieved at 23°C within 8 min using a high voltage of + 28 kV. The method validation included the determination of the detection limits (10 – 40 ng/ml) and the repeatability of migration time (0.2 – 0.3% RSD). The CE-MS procedure was successfully applied for the identification of amatoxins and phallotoxins in extracts of fresh and dried mushroom samples. 1. Introduction Over 90% of the lethal cases of mushroom toxin poisoning in man are caused by a species of Amanita [1].
    [Show full text]
  • Conceptual DFT As a Novel Chemoinformatics Tool for Studying
    Open Chem. 2019; 17:1133–1139 Research Article Norma Flores-Holguín, Juan Frau, and Daniel Glossman-Mitnik* Conceptual DFT as a Novel Chemoinformatics Tool for Studying the Chemical Reactivity Properties of the Amatoxin Family of Fungal Peptides https://doi.org/10.1515/chem-2019-0129 Received Sep 12, 2019; accepted Oct 24, 2019 1 Introduction Abstract: The chemical structures and molecular reac- Amatoxins are a group of deadly toxins found in Amanita tivities of the Amatoxin group of fungi-derived peptides fungi consisting of nine octapeptides with a bicycle struc- have been determined by means of the consideration of ture which are named as α-amanitin, β-amanitin, 훾- a model chemistry that has been previously validated as amanitin, ϵ-amanitin, amanullinic acid, amanin, amani- well-behaved for our purposes. The reactivity descriptors namide, amanullin and proamanullin. These toxins are of- were calculated on the basis of a methodological frame- ten associated with another group of bicyclic peptides, the work built around the concepts that are the outcome of the phallotoxins, which only contain seven amino acids in the so called Conceptual Density Functional Theory (CDFT). ring [1]. This procedure in connection with the different Fukui func- Amatoxins are found in mushrooms of the genera tions allowed to identify the chemically active regions Amanita, Galerina, Lepiota, and Conocybe from the fungal within the molecules. By considering a simple protocol phylum Basidiomycetes. α-amanitin poisoning causes irre- designed by our research group for the estimation of the versible liver damage and is responsible for 90% of fatal pKa of peptides through the information coming from the incidents with mushrooms.
    [Show full text]
  • ORIGINAL RESEARCH PAPER D. Slong JB Wahlang* Rangme B. Y
    PARIPEX - INDIAN JOURNAL OF RESEARCH | Volume-9 | Issue-1 | January - 2020 | PRINT ISSN No. 2250 - 1991 | DOI : 10.36106/paripex ORIGINAL RESEARCH PAPER Pharmacology MUSHROOM POISONING: IDENTIFICATION AND QUANTIFICATION OF TOXINS KEY WORDS: Amatoxins, Amanitin phalloides, Amanitin, WILL TOXINS IDENTIFICATION HELP IN HPLC Analysis PREVENTION OF ACCIDENTAL POISONING? D. Slong Assistant Professor, Forensic Medicine, NEIGRIHMS JB Wahlang* Assistant Professor, Pharmacology, NEIGRIHMS *Corresponding Author Rangme B. Y. Technical Assistant, Forensic Medicine, NEIGRIHMS Marbaniang Arky Jane Technical Assistant , Pharmacology, NEIGRIHMS Langstieh D. Ropmay Associate Professor, Forensic Medicine, NEIGRIHMS I. Tiewsoh Assistant Professor, General Medicine, NEIGRIHMS JA Lyngdoh Assistant Professor, Physiology, NEIGRIHMS Amatoxins commonly found in Amanita phalloides is the main constituents of toxins present in most toxic mushroom specimens containing α-amanitin, β-amanitin, γ-amanitin, ε-amanitin, amanin, amaninamide, amanullin, amanullinic acid, CT and proamanullin. RP-HPLC analysis of toxins Chromatography: The method of Ismail Yilmaz et. al, is followed using C18 (Agilent Technologies) at UV detection 303nm for amatoxins and 291nm for phallotoxins. The mobile phase in isocratic pump with a flow rate of 1ml/min consisting of 0.05M ammonium acetate (pH 5.5 with acetic acid) and acetonitrile (90:10v/v). The geographical variations determine the content of the toxins and it brings a landmark to create awareness ABSTRA to the community for such mushroom specimens. We hope that analyzing the toxin content in the coming years will be of great service to the Physician and the community as well. INTRODUCTION at the interface of subunits Rpb1 and Rpb2 following RNAP Amatoxins commonly found in Amanita phalloides is the main II/α-amanitin interactions.
    [Show full text]
  • WO 2016/071856 Al 12 May 2016 (12.05.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/071856 Al 12 May 2016 (12.05.2016) P O P C T (51) International Patent Classification: (74) Agent: RAYMOND, Daniel E ; c/o Novartis Pharmaceut C07K 7/64 (2006.01) A61P 35/00 (2006.01) icals Corporation, IP Services Mail Data, One Health Plaza A61K 38/12 (2006.01) 101/2, East Hanover, New Jersey 07936 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/IB2015/058537 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) Date: International Filing BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 5 November 20 15 (05 .11.20 15) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (26) Publication Language: English MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (30) Priority Data: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 62/076,023 6 November 2014 (06. 11.2014) US SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for all designated States except US) : NO- VARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (84) Designated States (unless otherwise indicated, for every (CH).
    [Show full text]